Accession Therapeutics
Phase 1Accession Therapeutics Limited is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumour diversity.
Founded
2019
Focus
Viral Technology
About
Accession Therapeutics Limited is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumour diversity.
Funding History
2Total raised: $25M
Series A$20MUndisclosedNov 15, 2022
Seed$5MUndisclosedMar 15, 2020
Company Info
TypePrivate
Founded2019
LocationOxford, United Kingdom
StagePhase 1
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile